2025
Optical Coherence Tomography Versus Angiography Alone to Guide PCI for Complex Lesions: A Meta-Analysis of Randomized Controlled Trials
Ezenna C, Krishna M, Joseph M, Ibrahim S, Pereira V, Jenil-Franco A, Nanna M, Bangalore S, Goldsweig A. Optical Coherence Tomography Versus Angiography Alone to Guide PCI for Complex Lesions: A Meta-Analysis of Randomized Controlled Trials. Circulation Cardiovascular Interventions 2025, 18: e015141. PMID: 40159113, DOI: 10.1161/circinterventions.125.015141.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionAdverse cardiovascular eventsRandomized Controlled TrialsOptical coherence tomographyMyocardial infarctionControlled TrialsCardiac deathCardiovascular eventsComplex lesionsRisk ratioMeta-analysis of randomized controlled trialsOCT-guided percutaneous coronary interventionHigh-resolution intracoronary imagingMajor adverse cardiovascular eventsAssociated with lower major adverse cardiovascular eventsMedian Follow-UpTarget vessel revascularizationPeriprocedural myocardial infarctionRandom-effects modelClinical outcomesCoherence tomographyFollow-upCochrane DatabaseCoronary interventionStent thrombosisOlezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence–TIMI 73b trial
Bergmark B, Marston N, Prohaska T, Alexander V, Zimerman A, Moura F, Kang Y, Murphy S, Zhang S, Lu M, Karwatowska-Prokopczuk E, Tsimikas S, Giugliano R, Sabatine M. Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence–TIMI 73b trial. American Heart Journal 2025, 286: 116-124. PMID: 40081744, PMCID: PMC12065083, DOI: 10.1016/j.ahj.2025.02.022.Peer-Reviewed Original ResearchMeSH KeywordsAgedApolipoprotein C-IIICardiovascular DiseasesClinical Trials, Phase III as TopicComputed Tomography AngiographyCoronary AngiographyDouble-Blind MethodFemaleHeart Disease Risk FactorsHumansHypertriglyceridemiaMaleMiddle AgedOligonucleotidesOligonucleotides, AntisenseRandomized Controlled Trials as TopicTriglyceridesConceptsCoronary Computed Tomography AngiographyCardiovascular riskTriglyceride levelsModerate hypertriglyceridemiaBaseline coronary computed tomography angiographyPlacebo-controlled phase 3 trialClearance of triglyceride-rich lipoproteinsApoC-IIIBaseline triglyceride levelsBaseline to 6 monthsLipid-Lowering TherapyAntisense oligonucleotidesNoncalcified coronary plaquesPhase 3 trialComputed tomography angiographyLowering triglyceride levelsIncreased cardiovascular riskElevated cardiovascular riskReduce cardiovascular riskAtherosclerotic cardiovascular diseaseTriglyceride-rich lipoproteinsPotential therapeutic strategyPooled placeboApolipoprotein C-IIIDouble-blindEconomic Outcomes With Precision Diagnostic Testing Versus Usual Testing in Stable Chest Pain: Results From the PRECISE Randomized Trial
Chew D, Mark D, Li Y, Nanna M, Kelsey M, Daniels M, Davidson-Ray L, Baloch K, Rogers C, Patel M, Anstrom K, Curzen N, Vemulapalli S, Douglas P, Investigators O. Economic Outcomes With Precision Diagnostic Testing Versus Usual Testing in Stable Chest Pain: Results From the PRECISE Randomized Trial. Circulation Cardiovascular Quality And Outcomes 2025, 18: e011008. PMID: 39895495, PMCID: PMC11837965, DOI: 10.1161/circoutcomes.123.011008.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngina, StableComputed Tomography AngiographyCoronary AngiographyCoronary Artery DiseaseCost SavingsCost-Benefit AnalysisFemaleFractional Flow Reserve, MyocardialHospital CostsHumansMaleMiddle AgedPredictive Value of TestsProspective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeUnited StatesConceptsChest painObstructive coronary artery diseaseCoronary computed tomographic angiographyStable chest painCoronary artery bypass surgeryLow-risk patientsSecondary end pointsPrimary composite of deathPrecision strategyComputed Tomographic AngiographyHealth care system perspectiveComposite of deathUS health care system perspectiveArtery bypass surgeryMedical costsMean cost differenceNonfatal myocardial infarctionCoronary artery diseaseIntention-to-treatPercutaneous coronary interventionUsual testsEstimated total medical costTotal medical costsClinical practice guidelinesRisk patientsThe comparative efficacy and safety of Tiger II versus judkins catheters in coronary angiogram via the radial artery access: a meta-analysis
Aljabali A, Alawajneh M, Hammad A, Nguyen D, Alkasabrah A, Abuein K, Altibi A. The comparative efficacy and safety of Tiger II versus judkins catheters in coronary angiogram via the radial artery access: a meta-analysis. Acta Cardiologica 2025, 80: 39-43. PMID: 39781598, DOI: 10.1080/00015385.2024.2442799.Peer-Reviewed Original ResearchMeSH KeywordsCardiac CatheterizationCardiac CathetersCoronary AngiographyCoronary Artery DiseaseEquipment DesignFluoroscopyHumansRadial ArteryConceptsStandardised mean differenceFluoroscopy timeContrast volumeProcedure timeJudkins catheterOdds ratioProcedural successCoronary angiogramTiger IIEstimates of odds ratiosRadiation exposureMeta-analysisReduced fluoroscopy timeRadial artery vasospasmRandom-effects modelWeb of ScienceRadial artery accessComplication rateArtery vasospasmSecondary outcomesPrimary outcomeComparative efficacyArterial accessTransfemoral accessCochrane Library
2024
Intravascular imaging-guided vs. angiography-guided percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials in high-risk patients and complex coronary anatomies
Teixeira L, Ferreira R, Navalha D, Pasqualotto E, Fae I, Gibicoski T, Chavez M, Talavera A, Athayde G, Chamie D. Intravascular imaging-guided vs. angiography-guided percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials in high-risk patients and complex coronary anatomies. International Journal Of Cardiology 2024, 416: 132510. PMID: 39222885, DOI: 10.1016/j.ijcard.2024.132510.Peer-Reviewed Original ResearchConceptsHigh-risk patientsPercutaneous coronary interventionMeta-analysis of randomized controlled trialsRandomized Controlled TrialsTarget vessel failureComplex coronary anatomyCoronary anatomyComplex lesionsRisk ratioCardiovascular mortalityStent thrombosisMyocardial infarctionControlled TrialsAngiography-guided percutaneous coronary interventionProcedure-related complicationsMeta-analysisRisk of MACEAdverse cardiac eventsConfidence intervalsSystematic reviewIntravascular imagingRandom-effects modelNo significant differenceCardiac eventsPrimary outcomeLow-density lipoprotein-cholesterol and subclinical coronary atherosclerosis in a middle-aged asymptomatic U.S. population: The Miami Heart Study at Baptist Health South Florida
Hagan K, Mszar R, Cainzos-Achirica M, Blaha M, Shapiro M, Arias L, Saxena A, Cury R, Budoff M, Feldman T, Fialkow J, Al-Kindi S, Nasir K. Low-density lipoprotein-cholesterol and subclinical coronary atherosclerosis in a middle-aged asymptomatic U.S. population: The Miami Heart Study at Baptist Health South Florida. Atherosclerosis 2024, 397: 118551. PMID: 39216228, DOI: 10.1016/j.atherosclerosis.2024.118551.Peer-Reviewed Original ResearchConceptsLow-density lipoprotein cholesterolCoronary artery calciumCAC 0Low-density lipoprotein cholesterol levelsHigh-risk plaquesCoronary plaquesNoncalcified plaqueLipoprotein cholesterolPlaque prevalenceCross-sectional analysisLow-density lipoprotein cholesterol <Cardiovascular risk categoryLow-risk groupCross-sectional analysis of baseline dataSubclinical coronary atherosclerosisHigher-risk groupsCardiovascular risk levelHeart StudyAnalysis of baseline dataArtery calciumAsymptomatic cohortAsymptomatic adultsCoronary atherosclerosisSubclinical atherosclerosisLow-risk participantsLipoprotein(a) and Coronary Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida
Mszar R, Cainzos-Achirica M, Valero-Elizondo J, Lahan S, Al-Kindi S, Quispe R, Ali S, Arias L, Saxena A, Shah S, Cury R, Budoff M, Blaha M, Shapiro M, Sharma G, Santos R, Blankstein R, Feldman T, Fialkow J, Nasir K. Lipoprotein(a) and Coronary Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida. Circulation Cardiovascular Imaging 2024, 17: e016152. PMID: 39012945, DOI: 10.1161/circimaging.123.016152.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAsymptomatic DiseasesBiomarkersComputed Tomography AngiographyCoronary AngiographyCoronary Artery DiseaseCoronary VesselsFemaleFloridaHumansLipoprotein(a)MaleMiddle AgedPlaque, AtheroscleroticPredictive Value of TestsPrevalenceProspective StudiesRisk AssessmentRisk FactorsUp-RegulationVascular CalcificationConceptsCoronary artery calcium scoreCoronary Computed Tomography AngiographyHigh-risk plaque featuresHigh-risk featuresArtery calcium scoreElevated Lp(aCoronary plaquesCalcium scorePlaque featuresHigh-risk coronary plaque featuresPresence of coronary plaqueRisk of atherosclerotic cardiovascular disease eventsClinical atherosclerotic cardiovascular diseaseLipid-Lowering TherapyCoronary plaque characteristicsAtherosclerotic cardiovascular disease eventsContemporary US cohortBaptist Health South FloridaCoronary plaque featuresAtherosclerotic cardiovascular diseaseAssessment of coronary atherosclerosisCardiovascular disease eventsNoninvasive gold standardAsymptomatic adultsIncreased riskInflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study
Chan K, Wahome E, Tsiachristas A, Antonopoulos A, Patel P, Lyasheva M, Kingham L, West H, Oikonomou E, Volpe L, Mavrogiannis M, Nicol E, Mittal T, Halborg T, Kotronias R, Adlam D, Modi B, Rodrigues J, Screaton N, Kardos A, Greenwood J, Sabharwal N, De Maria G, Munir S, McAlindon E, Sohan Y, Tomlins P, Siddique M, Kelion A, Shirodaria C, Pugliese F, Petersen S, Blankstein R, Desai M, Gersh B, Achenbach S, Libby P, Neubauer S, Channon K, Deanfield J, Antoniades C, Consortium O, Thomas S, Denton J, Farral R, Taylor C, Qin W, Kasongo M, Anthony S, Banning A, Xie C, Kharbanda R, Pritchard A, Halborg T, Syed N, Fry S, Mathers C, Rose A, Hudson G, Bajaj A, Das I, Deshpande A, Rao P, Lawday D, Mirsadraee S, Hudson B, Berry C, Marwan M, Maurovich-Horvat P, He G, Lin W, Fan L, Takahashi N, Kondo H, Dai N, Ge J, Koo B, Guglielmo M, Pontone G, Huck D, Benedek T, Rajani R, Vilic D, Aljazzaf H, Mun M, Benedetti G, Preston R, Raisi-Estabragh Z, Connolly D, Sharma V, Grenfell R, Bradlow W, Schmitt M, Serfaty F, Gottlieb I, Neves M, Newby D, Dweck M, Hatem S, Redheuil A, Benetos G, Beer M, Granillo G, Selvanayagam J, Lopez-Jimenez F, De Bosscher R, Tavildari A, Figtree G, Danad I, Shantouf R, Kietselaer B, Tousoulis D, Dangas G, Mehta N, Kontanidis C, Kunadian V, Fairbairn T. Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study. The Lancet 2024, 403: 2606-2618. PMID: 38823406, PMCID: PMC11664027, DOI: 10.1016/s0140-6736(24)00596-8.Peer-Reviewed Original ResearchConceptsObstructive coronary artery diseaseCoronary Computed Tomography AngiographyFat attenuation indexCoronary artery diseaseCardiac mortalityNational Health ServiceLongitudinal cohort studyConsecutive patientsRisk factorsPrognostic valueYears median follow-up periodAbsence of obstructive coronary artery diseaseCohort studyArtery diseaseInflammatory riskMedian follow-up periodAssociated with cardiac mortalityPerivascular fat attenuation indexCoronary arteryExtent of coronary artery diseaseTotal cardiac deathClinical risk stratificationAdverse cardiac eventsNational Institute for Health and Care ResearchClinical risk factorsSubclinical Atherosclerosis to Guide Treatment in Dyslipidemia and Diabetes Mellitus
Mszar R, Katz M, Grandhi G, Osei A, Gallo A, Blaha M. Subclinical Atherosclerosis to Guide Treatment in Dyslipidemia and Diabetes Mellitus. Current Atherosclerosis Reports 2024, 26: 217-230. PMID: 38662272, DOI: 10.1007/s11883-024-01202-w.Peer-Reviewed Original ResearchMeSH KeywordsAtherosclerosisComputed Tomography AngiographyCoronary AngiographyDiabetes Mellitus, Type 2DyslipidemiasHumansConceptsCoronary artery calciumType 2 diabetes mellitusAtherosclerotic cardiovascular diseaseDiabetes mellitusCardiovascular riskAtherosclerotic burdenIncreased CACComputed tomography coronary angiographyRisk of cardiovascular eventsIncreased risk of atherosclerotic cardiovascular diseaseLow-density lipoprotein cholesterolRisk of atherosclerotic cardiovascular diseaseMarkers of dyslipidemiaThoracic aorta calcificationCoronary Artery Calcium TestingStratify cardiovascular riskPrimary prevention settingSubclinical atherosclerotic burdenAorta calcificationCardiovascular disease preventionAssessment of subclinical atherosclerosisPrimary hypercholesterolemiaStatin therapyCoronary angiographyArtery calciumIs PET the Best Screening Tool for Cardiac Assessment Prior to Renal Transplant?
Sinusas A, Asch W. Is PET the Best Screening Tool for Cardiac Assessment Prior to Renal Transplant? Circulation Cardiovascular Imaging 2024, 17: e016408. PMID: 38227693, DOI: 10.1161/circimaging.123.016408.Peer-Reviewed Original ResearchIntravascular Imaging–Guided Versus Angiography‐Guided Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis of Randomized Trials
Sreenivasan J, Reddy R, Jamil Y, Malik A, Chamie D, Howard J, Nanna M, Mintz G, Maehara A, Ali Z, Moses J, Chen S, Chieffo A, Colombo A, Leon M, Lansky A, Ahmad Y. Intravascular Imaging–Guided Versus Angiography‐Guided Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis of Randomized Trials. Journal Of The American Heart Association 2024, 13: e031111. PMID: 38214263, PMCID: PMC10926835, DOI: 10.1161/jaha.123.031111.Peer-Reviewed Original ResearchConceptsAdverse cardiac eventsPercutaneous coronary interventionAngiography-guided percutaneous coronary interventionTarget vessel revascularizationTarget-lesion revascularizationCardiac eventsCardiac deathImaging-guided percutaneous coronary interventionWeighted mean follow-up durationMeta-analysisPrimary outcomeMean follow-up durationStent thrombosisMeta-analysis of randomized trialsStudy-level meta-analysisComplex lesion subsetsIntravascular imagingAll-cause deathRandom-effects meta-analysisStandard of careIntention-to-treat principleUpdates of clinical guidelinesMixed-effects meta-regressionComplex percutaneous coronary interventionIntravascular imaging-guided percutaneous coronary intervention
2023
Rationale and design of the INVICTUS Registry: (Multicenter Registry of Invasive and Non-Invasive imaging modalities to compare Coronary Computed Tomography Angiography, Intravascular Ultrasound and Optical Coherence Tomography for the determination of Severity, Volume and Type of coronary atherosclerosiS)
Nakanishi R, Okubo R, Sobue Y, Kaneko U, Sato H, Fujimoto S, Nozaki Y, Kajiya T, Miyoshi T, Ichikawa K, Abe M, Kitagawa T, Ikenaga H, Osawa K, Saji M, Iguchi N, Nakazawa G, Takahashi K, Ijich T, Mikamo H, Kurata A, Moroi M, Iijima R, Malkasian S, Crabtree T, Chamie D, Alexandra L, Min J, Earls J, Matsuo H. Rationale and design of the INVICTUS Registry: (Multicenter Registry of Invasive and Non-Invasive imaging modalities to compare Coronary Computed Tomography Angiography, Intravascular Ultrasound and Optical Coherence Tomography for the determination of Severity, Volume and Type of coronary atherosclerosiS). Journal Of Cardiovascular Computed Tomography 2023, 17: 401-406. PMID: 37679247, DOI: 10.1016/j.jcct.2023.08.011.Peer-Reviewed Original ResearchConceptsCoronary CT angiographyOptical coherence tomographyCoronary artery diseaseCoronary artery dimensionsInvasive imaging modalitiesImaging modalitiesCore laboratoryDiagnostic value of coronary CT angiographyCoronary arteryIntravascular ultrasoundArtery dimensionsCoronary atherosclerosis burdenEvaluating coronary artery diseaseImaging core laboratoryArtificial intelligenceNIRS-IVUSNoninvasive imaging modalityAtherosclerosis phenotypesCT angiographyProspective studyBlinded fashionCoherence tomographyAtherosclerosis burdenArtery diseaseDiagnostic valueComprehensive Management of ANOCA, Part 1—Definition, Patient Population, and Diagnosis JACC State-of-the-Art Review
Samuels B, Shah S, Widmer R, Kobayashi Y, Miner S, Taqueti V, Jeremias A, Albadri A, Blair J, Kearney K, Wei J, Park K, El-Farra A, Holoshitz N, Janaszek K, Kesarwani M, Lerman A, Prasad M, Quesada O, Reynolds H, Savage M, Smilowitz N, Sutton N, Sweeny J, Toleva O, Henry T, Moses J, Fearon W, Tremmel J, Network M. Comprehensive Management of ANOCA, Part 1—Definition, Patient Population, and Diagnosis JACC State-of-the-Art Review. Journal Of The American College Of Cardiology 2023, 82: 1245-1263. PMID: 37704315, DOI: 10.1016/j.jacc.2023.06.043.Peer-Reviewed Original ResearchMeSH KeywordsAngina PectorisCoronary AngiographyHumansMicrocirculationMyocardial BridgingMyocardial IschemiaConceptsCoronary function testingMyocardial bridgingCoronary angiographyMultiple medical providersNonobstructive coronary arteriesCoronary microvascular dysfunctionDiagnostic coronary angiographyIschemic heart diseaseInvasive coronary angiographyCoronary flow reserveCardiac catheterization laboratoryCoronary abnormalitiesCoronary vasospasmEpicardial spasmMicrocirculatory resistanceEndothelial dysfunctionMicrovascular dysfunctionHemodynamic assessmentProvocative testingCoronary arteryFunction testingPatient populationHeart diseaseJACC StateFlow reserveStandardized medical terminology for cardiac computed tomography 2023 update- commentary by North American Society of Cardiovascular Imaging (NASCI)
Rai A, Allen B, Fuss C, Dennie C, Hanneman K. Standardized medical terminology for cardiac computed tomography 2023 update- commentary by North American Society of Cardiovascular Imaging (NASCI). The International Journal Of Cardiovascular Imaging 2023, 39: 2255-2257. PMID: 37589871, DOI: 10.1007/s10554-023-02922-x.Peer-Reviewed Original ResearchMeSH KeywordsCoronary AngiographyHumansNorth AmericaPredictive Value of TestsSocieties, MedicalTomography, X-Ray ComputedUnited StatesConceptsCardiovascular imagingThe ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually
Foley M, Rajkumar C, Ahmed-Jushuf F, Nour D, Fung C, Seligman H, Pathimagaraj R, Petraco R, Sen S, Nijjer S, Howard J, Ahmad Y, Allahwala U, Bhindi R, Chamie D, Doi S, Kuwata S, Kaihara T, Koga M, Ishibashi Y, Higuma T, Tanabe Y, Nakayama M, Kawase Y, Watanabe A, Funayama N, Horinaka R, Hijikata N, Takahashi T, Matsuo H, Hansen P, Manica A, Weaver J, Alzuhairi K, Yong T, Warisawa T, Francis D, Shun-Shin M, Al-Lamee R. The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually. Cardiovascular Revascularization Medicine 2023, 59: 60-66. PMID: 37612169, DOI: 10.1016/j.carrev.2023.08.003.Peer-Reviewed Original ResearchConceptsInstantaneous wave-free ratioAmount of ischaemiaOptimal medical therapyVessel coronary artery diseaseSingle vessel coronary artery diseaseCoronary artery diseaseSingle vessel coronary diseaseVessel coronary diseaseInvasive pressure measurementsVisual assessmentLandmark trialsBlinded investigatorAngina trialArtery diseaseCoronary diseaseCoronary lesionsInvasive counterpartsInterventional cardiologistsVisual estimationCoronary stentingIschemic impactInvasive measurementsStentLesionsRandomized participantsComparison of intravascular ultrasound, optical coherence tomography, and conventional angiography‐guided percutaneous coronary interventions: A systematic review, network meta‐analysis, and meta‐regression
Park D, An S, Jolly N, Attanasio S, Yadav N, Gutierrez J, Nanna M, Rao S, Vij A. Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography‐guided percutaneous coronary interventions: A systematic review, network meta‐analysis, and meta‐regression. Catheterization And Cardiovascular Interventions 2023, 102: 440-450. PMID: 37483068, PMCID: PMC10908343, DOI: 10.1002/ccd.30784.Peer-Reviewed Original ResearchConceptsMajor adverse cardiovascular eventsPercutaneous coronary interventionOptical coherence tomographyCoronary angiographyIntravascular ultrasoundCoronary interventionCardiac deathClinical outcomesClinical efficacyConventional angiography-guided PCIAngiography-guided percutaneous coronary interventionCoherence tomographyUse of IVUSSuperiority of OCTAdverse cardiovascular eventsRandomized clinical trialsConventional coronary angiographyImaging modalitiesComparative clinical efficacyBest imaging modalityIntracoronary imaging modalityLesion revascularizationPCI guidanceCardiovascular eventsCause mortalityIoxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial.
Freitas R, Tanajura L, Mehran R, Chamié D, Chaves A, Centemero M, Braga S, Costa R, Cao D, Sousa A, Feres F, Costa J. Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial. Journal Of Invasive Cardiology 2023, 35: e281-e290. PMID: 37220640, DOI: 10.25270/jic/21.00249.Peer-Reviewed Original ResearchMeSH KeywordsAgedContrast MediaCoronary AngiographyCreatinineHumansIoxaglic AcidKidney DiseasesRisk FactorsTriiodobenzoic AcidsConceptsContrast-induced nephropathyNon-dialytic chronic kidney diseaseAcute coronary syndromePrevention of contrast-induced nephropathyChronic kidney diseaseHigh riskMean volume of contrast mediumDiabetes mellitusOccurrence of contrast-induced nephropathyKidney diseaseIso-osmolar contrastVolume of contrast mediumAcute coronary syndrome patientsIncreased risk of dialysisHigh-risk patientsRisk of dialysisAdverse cardiac eventsChronic heart failureContrast media administrationCoronary artery diseaseTreatment of coronary artery diseaseConsecutive patientsPrimary endpointNo significant differenceSingle-centerAdvances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care
Bienstock S, Lin F, Blankstein R, Leipsic J, Cardoso R, Ahmadi A, Gelijns A, Patel K, Baldassarre L, Hadley M, LaRocca G, Sanz J, Narula J, Chandrashekhar Y, Shaw L, Fuster V. Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care. JACC Cardiovascular Imaging 2023, 16: 1099-1115. PMID: 37178070, DOI: 10.1016/j.jcmg.2023.02.002.Peer-Reviewed Original ResearchConceptsCoronary Computed Tomography AngiographyCoronary artery diseaseAtherosclerotic plaquesArtery diseaseRisk stratificationPreventive carePlaque volumeHigh-risk plaque featuresNonobstructive coronary artery diseaseCoronary CTAMeasurements of atherosclerosisEffective risk stratificationHigh-risk patientsTotal plaque volumeComputed tomography angiographyPatient-specific factorsCoronary artery dimensionsIntravascular ultrasound measurementsHealth care systemCoronary dominanceCardiovascular preventionPatient subsetsPlaque featuresArtery sizeTomography angiographyPancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history
Wang C, Tian X, Feng X, Demuyakor A, Hu S, Wang Y, Li L, Cui L, Dong F, Dai J, Lei F, Xu Y, Du Z, Shi M, Liu J, Xing L, E M. Pancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history. Atherosclerosis 2023, 378: 117118. PMID: 37127496, DOI: 10.1016/j.atherosclerosis.2023.03.023.Peer-Reviewed Original ResearchConceptsAcute coronary syndrome patientsAcute coronary syndromeMaximum lipid arcOptical coherence tomographyThin-cap fibroatheromaCancer historyFibrous cap thicknessPercutaneous coronary interventionNonculprit lesionsLipid arcPrevalence of high-risk plaqueIncidence of thin-cap fibroatheromaCulprit lesionPrevalence of acute coronary syndromeHigh-risk plaque featuresHigher incidencePlaque characteristicsTime of percutaneous coronary interventionAssociated with high mortalityCharacteristics of coronary plaquesLipid indicesAbsence of cancer historyCoronary syndrome patientsNon-culprit lesionsIncidence of calcificationThe fat and the flow: multiparametric imaging assessment of pericoronary adipose tissue and myocardial blood flow
Csecs I, Feher A. The fat and the flow: multiparametric imaging assessment of pericoronary adipose tissue and myocardial blood flow. Journal Of Nuclear Cardiology 2023, 30: 1570-1573. PMID: 36929294, DOI: 10.1007/s12350-023-03247-x.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply